Connectivity Firm Credo Prices US$200 Million Nasdaq IPO

Connectivity solutions provider Credo Technology Group (Nasdaq: CRDO) started trading on the Nasdaq Global Select Market today. The California-based firm aims to raise US$200 million in its debut on the US big board.

The offering consisted of 20.0 million common shares at US$10.00 per share. Around 18.4 million shares are being offered by the company and the remaining 1.6 million shares by the selling shareholders. The shares will be trading on the Nasdaq exchange under the symbol “CRDO”.

Goldman Sachs & Co., Jefferies, and BofA Securities, Inc. are acting as the joint bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 3.0 million shares at the same IPO price.

Founded in 2008, the company also has its offices in North America and Asia. It said that its solutions are aimed “for next-generation platforms requiring 25G, 50G, and 100G signal lane-rate connectivity for 100G, 200G, 400G, and 800G port-enabled networks.” 


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Why Silver Still Hasn’t Seen the Real Mania | Craig Hemke

Why Copper Needs a Much Higher Price to Fix the Supply Problem | Greg Ferron – PTX Metals

Recommended

Crossroads Gold Closes Rox-ex Acquisition, Adds Pambula and Club Terrace to Australian Pipeline

Goliath Resources Kicks Off Fully Funded 50,000 Metre Drill Program At Surebet

Related News

Fintech Firm-Backed SPAC FTAC Emerald Acquisition Prices US$220 Million IPO

Special purpose acquisition company FTAC Emerald Acquisition Corp. (Nasdaq: EMLDU) started trading publicly on the...

Thursday, December 16, 2021, 02:22:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Biotech Firm HilleVax Prices US$200 Million IPO

Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on...

Monday, May 2, 2022, 02:25:00 PM

Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go...

Wednesday, February 9, 2022, 02:27:00 PM

Investment Firm-Backed SPAC Sound Point Acquisition I Prices Upsized US$225 Million IPO

Special purpose acquisition company Sound Point Acquisition Corp I (Nasdaq: SPCMU) started trading publicly on...

Wednesday, March 2, 2022, 02:23:00 PM